ArticleScientific reports2021
A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis.
Open access · goldAbstract read
In one paragraph
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.
- ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease.The European respiratory journal · 2026Guideline
- A systematic review of the role of quantitative CT in the prognostication and disease monitoring of interstitial lung disease.European respiratory review : an official journal of the European Respiratory Society · 2025Pooled it
- High-resolution computed tomography assessment of connective tissue disease-associated interstitial lung disease: Advances in diagnosis and prognostic evaluation.World journal of radiology · 2026Review
- Prediction of intravenous cyclophosphamide treatment efficacy in idiopathic inflammatory myopathies-associated interstitial lung disease patients: a nomogram based on radiomics and clinical factors.BMC pulmonary medicine · 2026Article
- Machine learning for predicting acute exacerbation and mortality in idiopathic inflammatory myopathy-associated interstitial lung disease.Frontiers in medicine · 2026Article
- Clinical features and prognostic factors of anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease with spontaneous mediastinal emphysema: a retrospective case series of nine patients.Frontiers in medicine · 2026Article
- Severe interstitial lung disease risk prediction in anti-melanoma differentiation-associated protein 5 positive dermatomyositis: the STRAD-Ro52 model.Annals of medicine · 2025Article
- SARS-CoV-2 reinfection in interstitial lung disease patients and its association with clinical deterioration: a two-year prospective cohort study.BMC infectious diseases · 2025Article
- Longitudinal change of idiopathic inflammatory myopathy-associated interstitial lung disease on high-resolution computed tomography, a prospective cohort study.BMC pulmonary medicine · 2025Article
- Interstitial Lung Disease Outcome Prediction Using Quantitative Densitometry Indices on Baseline Chest Computed Tomography.Diagnostics (Basel, Switzerland) · 2025Article
- Spontaneous pneumomediastinum and/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system.Respiratory research · 2025Article
- Mortality Risk Prediction in Patients With Antimelanoma Differentiation-Associated, Gene 5 Antibody-Positive, Dermatomyositis-Associated Interstitial Lung Disease: Algorithm Development and Validation.Journal of medical Internet research · 2025Article
- Quantitative Imaging Markers on HRCT Predict Rapid Progression and Adverse Events of Patients with Idiopathic Inflammatory Myopathies-Related Interstitial Lung Disease.International journal of general medicine · 2025Article
- Development of a machine learning model in prediction of the rapid progression of interstitial lung disease in patients with idiopathic inflammatory myopathy.Quantitative imaging in medicine and surgery · 2024Article
- Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis Without Cutaneous Findings or Rapidly Progressive Lung Disease: A Case Report.Journal of general internal medicine · 2024Article
- Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports.Rheumatology international · 2024Review
- Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study.Respiratory research · 2024Article
- Multivariate logistic regression analysis of poor prognosis of dermatomyositis and clinical value of ferritin/Kl-6 in predicting prognosis.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024Article
- In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell lines.Clinical and translational science · 2024Article
- Anti-MDA5 dermatomyositis: an update from bench to bedside.Current opinion in rheumatology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Wenwen Xu *Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Wanlong Wu *Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Danting ZhangDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Zhiwei ChenDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Xinwei TaoCT Scientific Collaboration, Siemens Healthineers, Shanghai, China.
Jiangfeng ZhaoDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Kaiwen WangDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Xiaodong WangDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China.
Yu ZhengDepartment of Pulmonology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China. drzhengyu@yahoo.com.
Shuang YeDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, No. 2000 Jiangyue Road, Shanghai, 201112, China. ye_shuang2000@163.com.
Shanghai Jiao Tong University · CNRenji Hospital · CNSiemens Healthcare (United States) · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated interstitial lung disease (MDA5
Indexed as
Artificial IntelligenceDermatomyositisFemaleHumansInterferon-Induced Helicase, IFIH1Lung Diseases, InterstitialMalePrognosisRadiographic Image Interpretation, Computer-AssistedTomography, X-Ray ComputedIFIH1 protein, humanInterferon-Induced Helicase, IFIH1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.